Table 3 Prevalence of HIV infection among HIV-exposed children by PMTCT programme indicators and maternal demographic characteristics, Rwanda PMTCT programme, 2009
Characteristics | HIV-positive children (%) | Univariate analysis (p) | Multivariate analysis | |
|---|---|---|---|---|
| Â | Â | Â | OR | 95%CI |
Child received ARV at birth (n = 1340) | Â | 0.3 | Â | Â |
None (reference) | 6.5 | Â | 1 | Â |
NVP | 4.5 | Â | 0.7 | 0.2-2.2 |
Dual therapy | 3.6 | Â | 0.5 | 0.2-2.1 |
Don't know | 2.9 | Â | 0.4 | 0.1-1.9 |
Mother delivered at health centre (n = 1336) | Â | 0.4 | Â | Â |
Yes | 3.8 | Â | 0.9 | 0.3-3.0 |
No (reference) | 5.2 | Â | 1 | Â |
Feeding options at birth (n = 1303) | Â | 0.1 | Â | Â |
EBF (reference) | 3.4 | Â | 1 | Â |
BF and early cessation | 4.0 | Â | 0.9 | 0.4-1.7 |
Formula | 2.3 | Â | 0.7 | 0.2-2.4 |
Animal modified milk | 1.2 | Â | 0.3 | 0.0-2.5 |
Number of ANC visits (n = 1340) | Â | 0.4 | Â | Â |
Less than four (reference) | 4.3 | Â | 1 | Â |
Four or more | 3.5 | Â | 1.2 | 0.6-2.1 |
ARV and/or cotrimoxazole taken by the mother (n = 1333) | Â | 0.05 | Â | Â |
None (reference) | 5.4 | Â | 1 | Â |
Cotrimoxazole | 3.1 | Â | 0.6 | 0.3-1.4 |
NVP alone | 7.0 | Â | 1.2 | 0.5-3.0 |
Dual therapy | 4.8 | Â | 1.1 | 0.4-3.0 |
Triple therapy | 1.9 | Â | 0.4 | 0.1-0.96* |
Mother's age (years) (n = 1337) | Â | 0.01* | Â | Â |
15-24 (reference) | 6.8 | Â | 1 | Â |
25-29 | 4.8 | Â | 0.9 | 0.4-2.3 |
30-34 | 4.7 | Â | 0.8 | 0.3-1.9 |
35-39 | 1.5 | Â | 0.3 | 0.1-0.9 |
40-49 | 3.0 | Â | 0.6 | 0.2-2.0 |